Heart Attacks are Preventable!

Welcome to my podcast, I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist, a private practice of over 10,000 patients.

Australia, like the rest of the western world, has a heart problem.

Over 9 million people around the world die from heart disease every year.

Every 10 minutes, someone in Australia suffers a heart attack. And 21 lives are lost daily because of it.

The devastating fact in all this is… 

Almost every one of those cases could have been prevented. 

This podcast is for anyone who wants to improve their health literacy and gain information to help them make the best decisions about their risk of heart attack, their cholesterol, blood pressure, risk of diabetes, weight loss and general health. Join me on my personal mission journey to prevent Heart Attack on a global scale. If you like this podcast I would be honoured with a 5-star review and let your friends and family know, you may even save the life of someone you love!

Episodes

EP65: Middle of the Night Phone Call

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Introduction Dr. Warrick Bishop is a practicing cardiologist and author dedicated to improving patient care through heart health education. In this episode, Dr. Bishop shares a deeply personal and life-saving story about his friend Craig, who experienced sudden chest pain in his mid-30s and the critical importance of seeking immediate medical attention when something doesn't feel right. The episode serves as a powerful reminder that cardiac events can happen to seemingly healthy, young people and that trusting your instincts about unusual symptoms can be the difference between life and death. Key Takeaways: Unexplained chest pain, especially if it's different from anything you've experienced before, warrants immediate hospital evaluation regardless of age or perceived risk factors. Trust your instincts: if a symptom doesn't feel right and you're compelled to seek help in the middle of the night, that intuition is worth acting on. Young, apparently healthy people with minimal risk factors can still suffer serious cardiac events without warning. Cardiac symptoms can present in atypical ways beyond just chest pain—including arm aches, jaw aches, shoulder aches, or sensations resembling indigestion. The potential consequences of not seeking medical care (death at home) far outweigh the minor inconvenience of a hospital visit that turns out to be nothing. Having access to emergency medical equipment, defibrillators, and trained personnel in a hospital setting can be the difference between life and death, as demonstrated by Craig's two cardiac arrests requiring resuscitation. If you experience any unexplained symptoms between your eyeballs and belly button, seek medical evaluation rather than trying to self-diagnose or wait it out. Early intervention and proper diagnosis (Craig received a stent in his left anterior descending artery) can successfully save lives and allow patients to continue living with their families. Read more

EP64: Energy Drink Project

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary: Energy Drinks Dr. Warrick Bishop is a practicing cardiologist and education advocate who hosts a podcast dedicated to improving patient understanding of heart health. In this episode, he provides a comprehensive examination of energy drinks, exploring their history, composition, purported benefits, and cardiovascular and psychological risks. The discussion is particularly relevant given the widespread consumption of these beverages among teenagers and young adults globally. Key Takeaways: Energy drinks emerged in the global market in 1987 with Red Bull, and by 2013 the industry had grown to a 12.5 billion dollar market with consumption exceeding 5.8 billion liters annually across 160 countries. The primary active ingredient in energy drinks is caffeine (ranging from 30-140mg), which is often combined with high sugar content to provide both stimulation and a sugar rush to consumers. While some research suggests energy drinks can improve aerobic endurance, mood, alertness, and response times, many studies show no significant benefit, making the evidence mixed at best. High doses of caffeine from excessive energy drink consumption can cause dangerous cardiovascular effects including abnormal heart rhythms, increased blood pressure, endothelial dysfunction, and increased risk of heart attacks. Neurological side effects of energy drinks include anxiety, insomnia, gastrointestinal upset, restlessness, agitation, and in severe cases (over 300mg caffeine), hallucinations and seizures. The high sugar content in energy drinks contributes to tooth decay, potential gut microbiome changes, reduced insulin sensitivity, and increased weight gain risk with long-term consumption. Caffeine has a diuretic effect that can lead to dehydration, particularly concerning when combined with exercise and a sense of energetic wellbeing that masks fluid loss. Energy drinks negatively impact sleep quality despite their wakefulness effects, leaving consumers depleted the following day with no net gain in rest or performance. Mixing energy drinks with alcohol creates a false sense of capability and safety, as the stimulant effect masks alcohol impairment without actually reducing it, leading to increased risky behavior. Energy drink consumption among university-age students has been associated with increased risky behaviors including unsafe driving, drug use, and sexual risk-taking. The psychological effects on teenagers are particularly concerning, as the combination of caffeine and sugar impacts concentration, mood, and decision-making processes during critical developmental years. Read more

EP63: What Is Circulation?

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Introduction Dr. Warrick Bishop, a practicing cardiologist and author, hosts this educational podcast from his home to simplify understanding of the circulatory system. He believes educated patients receive the best healthcare and aims to demystify how the circulation works by breaking down often-confusing medical diagrams into easy-to-understand concepts. Today's episode focuses on explaining the basic mechanics of blood circulation and the heart's role in maintaining continuous flow throughout the body. Key Takeaways: The primary purpose of circulation is to deliver oxygen from the lungs to body tissues and remove waste products (carbon dioxide) from those tissues. The circulation can be understood as one continuous circle: oxygen-rich blood flows from the lungs to tissues through arteries and capillaries, where gas exchange occurs, then returns to the lungs through veins. The heart functions as a pump with one-way valves that ensure blood flows in only one direction, preventing backflow and maintaining continuous circulation. Oxygen-rich blood from the lungs enters the left atrium, moves to the left ventricle (the body's major pumping chamber), and is then propelled through the aorta to the entire body. Deoxygenated blood returns through two major veins (superior and inferior vena cava) into the right atrium, then right ventricle, and is pumped to the lungs for gas exchange. Different organs receive varying percentages of blood flow based on need: the brain and kidneys each receive nearly 25% of total circulation, while the gut and muscles receive variable amounts depending on activity and digestion. Veins contain one-way valves and are assisted by external muscle compression and negative chest pressure to push blood back toward the heart against gravity. Understanding circulation mechanics helps patients comprehend how problems in specific locations can have downstream effects throughout the cardiovascular system. Read more

EP62: The Spray Under The Tongue

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Introduction: Dr. Warrick Bishop is a practicing cardiologist and author dedicated to educating patients about heart health. In this episode, he discusses an important misconception about sublingual glycerol trinitrate (GTN) spray—the medication sprayed under the tongue for angina chest pain—and explains how its appropriate use differs significantly between stable and unstable angina situations. Key Takeaways: GTN spray is a vasodilator that works by dilating blood vessels to increase blood flow to the heart and reduce anginal pain, though it can cause headaches as a side effect. Stable angina is predictable chest pain that occurs with consistent triggers (like walking a certain distance), whereas unstable angina comes on unexpectedly with minimal exertion or at rest. In stable angina, relying on GTN spray suggests the patient is undertreated with their regular anti-anginal medications and should see a cardiologist to adjust their treatment plan rather than use the spray as a management solution. In unstable angina, GTN spray may temporarily relieve pain but does not address the underlying problem—likely a ruptured plaque with clot formation that could lead to a heart attack. Pain relief from GTN spray in unstable angina should be viewed as a warning sign, not reassurance; it indicates the need for immediate hospital evaluation, not comfort at home. Patients should never assume that GTN spray resolving chest pain means the danger has passed; this false sense of security can delay critical emergency care. Unstable angina represents a serious, high-risk condition that requires urgent hospitalization and proper investigation rather than self-treatment with sublingual medication. Read more

EP61: A1 And A2 Milk

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Introduction: Dr. Warrick Bishop is a practicing cardiologist and author dedicated to educating patients about heart health and the latest advances in cardiac care. In this episode, he explores the difference between A1 and A2 milk proteins, examining the scientific evidence around whether A2 milk offers health advantages over the more commonly consumed A1 milk. The discussion covers the history of milk mutations, proposed mechanisms of difference, and the current state of research on this increasingly popular food debate. Key Takeaways: A1 and A2 milk differ due to a mutation in beta casein that occurred approximately 8,000 years ago, with A1 milk becoming dominant in Western dairy industries through breeding practices. A1 beta casein may trigger the release of beta-casomorphin in the small intestine, which has been theoretically linked to altered gut function and increased inflammatory cells compared to A2 milk. Observational studies have suggested potential associations between A1 milk consumption and type 1 diabetes, autism, coronary artery disease, and schizophrenia, though causation has not been established. Many A2 milk studies have been funded by A2 milk producers, creating bias concerns, while independent research in 2014 failed to replicate health benefits claimed in company-sponsored studies. A 2017 randomized, double-blind crossover trial with 600 Chinese adults demonstrated that A2 milk reduced gastrointestinal symptoms like bloating and abdominal pain specifically in lactose-intolerant individuals. Currently, there is insufficient scientific evidence to recommend A2 milk over A1 milk for the general population, though lactose-intolerant individuals may experience benefits. Dr. Bishop recommends that people concerned about milk tolerance conduct self-blinded experiments comparing A1 and A2 over 24-48 hours to observe personal differences. A conflict of interest was discovered when a researcher who dismissed A2 milk claims in 2006 was later revealed to be a consultant for the New Zealand dairy industry. Read more

EP60: Progress to Bypass Grafting

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Introduction Dr. Warrick Bishop, a practicing cardiologist and advocate for patient education, hosts this episode featuring Bruce, a 74-year-old patient who has recently undergone cardiac evaluation and diagnosis. Bruce shares his personal journey through heart healthcare, prompted by his brother's cardiac events and family history of heart disease, offering valuable insights for listeners facing similar cardiovascular health concerns. Key Takeaways Family history of heart disease is a significant risk factor; Bruce's father had a triple bypass in his 60s, and his brother had a heart attack and cardiac arrest at age 52, prompting Bruce's own cardiac evaluation at age 73. Advanced imaging (CT scan) can be more informative than stress testing in asymptomatic, fit-appearing patients to detect arterial plaque and assess true cardiovascular risk. Serial stress testing over time can help track disease progression; Bruce's treadmill tests showed changes between tests performed six months apart, indicating advancing coronary artery disease. Subtle changes in physical symptoms—such as unusual shortness of breath during routine activity—can be early warning signs that should be reported to both doctors and family members immediately. Early detection through preventative screening and imaging allowed intervention before acute cardiac events occurred, avoiding the life-threatening emergency situations Bruce's brother experienced. Invasive coronary angiography provides the highest resolution imaging needed to plan specific treatment strategies and confirm the extent of arterial blockages. Coronary artery bypass grafting, while requiring surgery, offers superior outcomes when planned electively compared to emergency procedures performed after heart attacks or cardiac arrest. Patient education about the "why" behind medical procedures reduces fear and increases compliance; understanding the reasoning helps patients approach necessary surgery with realistic optimism. Family members with a diagnosed cardiac condition should prompt screening of siblings, as genetic and shared risk factors make them statistically higher risk for similar disease. Delaying medical evaluation of potential cardiac symptoms can result in catastrophic outcomes; early action and getting symptoms "checked out" can be lifesaving. Read more

EP59: Consultation With A Patient That Doesn't Want To Take Statins

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Introduction Dr. Warrick Bishop, a practicing cardiologist and author, hosts a consultation with his patient Michael, a 72-year-old previously fit and active man who recently suffered a heart attack and received a stent placement in his LAD artery. The episode focuses on addressing Michael's significant apprehension about taking statin therapy, which stems largely from misinformation he encountered online about statins and dementia. Key Takeaways: Michael's reluctance to take statins is primarily driven by fear that they cause cognitive decline and dementia, based on research he found on YouTube and the internet rather than medical evidence. The FDA conducted a thorough review of statins and found absolutely no evidence from clinical trials that they cause any decrease in mental cognition, despite investigating concerns about memory issues. Statins likely do not affect brain cholesterol because they do not cross the blood-brain barrier, and newborns naturally have LDL cholesterol levels of 0.6-0.7 mmol/L—far lower than typical adult levels—without developmental problems. Statins may actually help prevent dementia indirectly by reducing vascular events (strokes and mini-strokes caused by cholesterol buildup in brain arteries), which are a significant cause of dementia. Internet information about statins is often biased and disproportionately amplified by individuals with financial interests in creating controversy, whereas peer-reviewed medical evidence and professional guidelines are based on rigorous research. In secondary prevention cases like Michael's (after a cardiac event), lowering cholesterol through statins is supported by extensive evidence to stabilize plaque and reduce future cardiac events. Idiosyncratic side effects to statins do exist in some patients, but these are not dose-related and are not replicated across the broader patient population, and serious complications like rhabdomyolysis are extremely rare (1 in 70,000). Dr. Bishop does not advocate prescribing statins based solely on cholesterol numbers; he emphasizes the importance of imaging and risk assessment to determine who truly benefits from cholesterol-lowering therapy. Australian lipid guidelines have evolved based on new research, with current secondary prevention targets being an LDL level of 1.8 mmol/L or lower, which Michael's baseline of 2.4 exceeds. Read more

EP58: Consultation About Statin Intolerance

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary: EP58 - Consultation About Statin Intolerance Introduction Dr. Warwick Bishop, a practicing cardiologist and patient education advocate, conducts a recorded consultation with Brad, a long-term patient with coronary artery plaque, and his wife Joan. The episode explores Brad's recent experience with apparent statin intolerance, featuring joint pain, muscle aches, night sweats, and other symptoms that improved after stopping pravastatin and ezetimibe, while discussing the complexity of distinguishing true drug side effects from other causes. Key Takeaways: A landmark study found that 70% of patients who claimed they couldn't tolerate statins were actually able to take them without side effects when tested in a double-blind, randomized crossover trial, suggesting statins are frequently blamed for unrelated symptoms. About 30% of patients do experience genuine statin side effects, making it crucial to systematically test whether symptoms are truly drug-related rather than assuming causation. Brad's case is particularly important because he tolerated pravastatin well for 10 years without problems, suggesting his recent symptoms may have other causes unrelated to the statin itself. Ezetimibe (a cholesterol-lowering agent) rarely causes side effects because it primarily acts in the gut and is not significantly absorbed into the bloodstream, making it an uncommon culprit for systemic symptoms. Pravastatin should be taken in the evening because it has a shorter half-life and requires the liver's peak metabolic activity during sleep to work effectively. Dr. Bishop's treatment approach prioritizes finding a solution that allows Brad to tolerate medication while managing his high-risk coronary plaque at the distal left main artery, which could suddenly close and cause death without treatment. Multiple alternative options exist if pravastatin proves problematic, including switching to rosuvastatin or using newer PCSK9 inhibitors that work through different mechanisms and may be better tolerated. Patients should never stop cardioprotective medications without consulting their doctor, as this leaves serious cardiac risks unmanaged while the cause of symptoms is determined. Dark urine observed during medication use may indicate dehydration rather than drug toxicity, and symptoms should be monitored systematically when reintroducing medications. Read more

EP57: Second Interview With Senior Gastroenterologist Gautam Ramnath

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode Summary Introduction: Dr. Warwick Bishop, a practicing cardiologist and podcast host, welcomes back Dr. Gautham Ramnath, a senior gastroenterologist from Brisbane with over a decade of private practice experience and additional training in geriatrics and pharmacology. This episode focuses on the challenging clinical overlap between chest pain caused by reflux/gastrointestinal issues versus cardiac-related chest pain, and how both specialists approach diagnosis and management. Key Takeaways: Patient history and symptom description are the most critical starting point for differentiating reflux from cardiac chest pain—specifically listening for acid burning sensations, taste of food, or pain triggered by exertion. Both gastroenterologists and cardiologists treat all chest pain as potentially cardiac in origin initially due to serious health consequences, even when gastrointestinal causes seem likely. Chest pain perception is imprecise because nerves are distributed in bands across the chest; both reflux and cardiac conditions can cause similar segmental pain patterns, making differentiation difficult. Alarm features requiring urgent endoscopic evaluation include dysphagia (difficulty swallowing), anemia, iron deficiency, waking up with food in mouth, and changes in swallowing—dysphagia is the gastroenterology equivalent of crushing chest pain on exertion. Topical antacids (like Gaviscon) can be used as a diagnostic trial in younger patients; if symptoms resolve quickly, it suggests local gastrointestinal inflammation rather than cardiac disease. Upper endoscopy is a safe, minimally invasive procedure (major complication rate <1 in 2,000-3,000) that provides direct visual assessment of the esophagus and stomach to identify damage severity, precancerous changes, and determine the exact problem location. Alcohol is a major caustic irritant that severely impedes resolution of esophageal and gastric ulceration and should be identified during patient evaluation. Certain medications can cause reflux-like symptoms: doxycycline (antibiotic) can cause focal ulcers, asthma inhalers can cause candida/thrush infection (commonly misdiagnosed as reflux), and other caustic agents may irritate the esophagus. Functional disorders involving misfiring nerves can present with reflux-like symptoms even when no physical inflammation is present, requiring different treatment approaches. Read more

EP56: Interview With Senior Gastroenterologist Gautam Ramnath

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary: EP56 - Aspirin and Gastrointestinal Health Introduction Dr. Warwick Bishop, a practicing cardiologist and author focused on patient education, interviews Dr. Gautam Ramnath, a senior gastroenterologist from Queensland with over 10 years of experience in gastroenterology practice in Brisbane. The episode explores aspirin from two opposing medical perspectives—its cardiovascular benefits versus its gastrointestinal risks—to help patients understand the complex trade-offs involved in aspirin therapy. Key Takeaways: Aspirin has a "double whammy" effect on gastrointestinal bleeding: it removes the stomach's protective mucus coating while simultaneously impairing the blood's ability to clot, creating a compounded bleeding risk. Aspirin causes stomach ulcers through systemic action after being absorbed into the bloodstream, not through direct contact in the stomach, meaning enteric-coated aspirin offers no meaningful protection. Enteric-coated aspirin preparations provide primarily psychological reassurance rather than clinical benefit, with no scientific evidence showing reduced bleeding complications compared to regular aspirin. The current standard aspirin dose of 100 milligrams in Australia lacks clear evidence of equivalence to the original 300-600 milligram doses used in landmark trials that proved aspirin's cardiovascular benefit. The assumption that lower aspirin doses provide the same cardiac protection as higher doses remains unsubstantiated, potentially undermining current prescribing guidelines. A gastroenterologist with cardiac risk would choose 300 milligrams of aspirin daily, acknowledging the lack of definitive trials proving that lower doses are equally effective. Platelet resistance is a recognized phenomenon where clotting cells may not respond adequately to aspirin, potentially requiring higher doses for efficacy in many patients. Cost-benefit analysis suggests generic soluble aspirin from commercial sources performs similarly to expensive enteric-coated preparations. Read more